newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics Appoints Dr. Ingmar Bruns as Chief Medical Officer

CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative...